Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus

Yasuto Araki,Toshihide Mimura
DOI: https://doi.org/10.3390/ijms25021019
IF: 5.6
2024-01-14
International Journal of Molecular Sciences
Abstract:Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease in which immune disorders lead to autoreactive immune responses and cause inflammation and tissue damage. Genetic and environmental factors have been shown to trigger SLE. Recent evidence has also demonstrated that epigenetic factors contribute to the pathogenesis of SLE. Epigenetic mechanisms play an important role in modulating the chromatin structure and regulating gene transcription. Dysregulated epigenetic changes can alter gene expression and impair cellular functions in immune cells, resulting in autoreactive immune responses. Therefore, elucidating the dysregulated epigenetic mechanisms in the immune system is crucial for understanding the pathogenesis of SLE. In this paper, we review the important roles of epigenetic disorders in the pathogenesis of SLE.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role of epigenetic dysregulation in the pathogenesis of systemic lupus erythematosus (SLE). Specifically, the article aims to: 1. **Clarify the importance of epigenetic mechanisms in the pathogenesis of SLE**: By reviewing existing research, the article emphasizes how epigenetic changes affect gene expression and immune cell function, leading to autoimmune responses. These epigenetic changes include alterations in DNA methylation, histone modification, and microRNA expression. 2. **Reveal the specific mechanisms of epigenetic dysregulation in SLE**: The article discusses in detail the abnormal manifestations of DNA methylation, histone modification, and microRNA expression in SLE patients, and analyzes how these changes affect the function of the immune system, especially the dysregulation of adaptive and innate immunity. 3. **Explore new treatment strategies**: By gaining a deep understanding of the epigenetic dysregulation mechanisms in SLE, the article provides a theoretical basis for the development of new treatment methods. For example, by modulating specific epigenetic marks, it may be possible to restore normal immune function and thus alleviate the symptoms of SLE. ### Main content overview - **Introduction**: Introduces the basic characteristics of SLE, including its clinical manifestations, the influence of genetic and environmental factors, and current treatment methods. - **Pathogenesis of SLE**: - **Adaptive immune response**: Discusses the roles of T cells and B cells in SLE, including the functions of Tfh cells, Tph cells, and age - related B cells (ABCs) and their contributions to disease development. - **Innate immune response**: Explores the roles of Toll - like receptor (TLR) - dependent and - independent pathways in SLE, as well as the impact of neutrophil extracellular traps (NETs) formation on the disease. - **Epigenetic regulation**: - **Regulation of chromatin structure and gene transcription**: Explains the roles of DNA methylation, histone modification, and microRNA in regulating gene expression. - **Epigenetic dysregulation in SLE**: - **Dysregulation of DNA methylation**: Describes in detail the hypomethylation of genes such as CD11a/CD18, CD70, CD40LG and their roles in SLE. - **Dysregulation of histone modification**: Discusses the changes in histone modifications such as H3K4me3, H3K27me3 and their effects on gene expression. - **Dysregulation of microRNA expression**: Analyzes the expression changes of microRNAs such as miR - 10b - 5p, miR - 21, miR - 146a in SLE and their effects on immune cell function. Through these contents, the article comprehensively expounds the crucial role of epigenetic dysregulation in the pathogenesis of SLE and provides directions for future research and treatment.